ConductScience.org, home

Paper39276358

Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease.

Huang L and 6 others. Ann Med, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease. Papers, record 39276358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39276358

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease.
PubMed
Journal
Ann Med
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.41, provisional
iCite
Revised in PubMed
2026-06-12
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang LLidong
2Guan QQingzhouhttps://orcid.org/0000-0001-7741-6440
3Lu RRuilong
4Zhang ZZhenzhen
5Liu CChunlei
6Tian YYange
7Li JJianshenghttps://orcid.org/0000-0002-6485-2371

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pulmonary Disease, Chronic ObstructiveMajor topic
Drugs, Chinese HerbalMajor topic
Protein Interaction MapsMajor topic
Molecular Docking SimulationMajor topic
Animals
Rats
Male
Disease Models, Animal
Exercise Therapy
Physical Conditioning, Animal
Rats, Sprague-Dawley
Combined Modality Therapy

Source PubMed

Download CSV of topics

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134562363Structural basis and regulation of the reductive stress response.Cell2021https://conductscience.org/library/papers/34562363PubMed
229616282A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells.Inflamm Res2018https://conductscience.org/library/papers/29616282PubMed
334086934KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis.Nucleic Acids Res2021https://conductscience.org/library/papers/34086934PubMed
426747783p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure.Am J Physiol Lung Cell Mol Physiol2016https://conductscience.org/library/papers/26747783PubMed
537353334Oxygen Therapy in COPD.Respir Care2023https://conductscience.org/library/papers/37353334PubMed
632526187Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet Respir Med2020https://conductscience.org/library/papers/32526187PubMed
727822031Effects of aerobic training combined with respiratory muscle stretching on the functional exercise capacity and thoracoabdominal kinematics in patients with COPD: a randomized and controlled trial.Int J Chron Obstruct Pulmon Dis2016https://conductscience.org/library/papers/27822031PubMed
836858443Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.Eur Respir J2023https://conductscience.org/library/papers/36858443PubMed
938032494Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns.Postgrad Med2023https://conductscience.org/library/papers/38032494PubMed
1031075101Pathway-specific protein domains are predictive for human diseases.PLoS Comput Biol2019https://conductscience.org/library/papers/31075101PubMed
1128605262Chronic Obstructive Pulmonary Disease: From Injury to Genomic Stability.COPD2017https://conductscience.org/library/papers/28605262PubMed
1233689672RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.Am J Respir Cell Mol Biol2021https://conductscience.org/library/papers/33689672PubMed
1335856181Mechanical ventilation and COPD: from pathophysiology to ventilatory management.Minerva Med2022https://conductscience.org/library/papers/35856181PubMed
1434188688The Effectiveness of Traditional Chinese Medicine (TCM) as an Adjunct Treatment on Stable COPD Patients: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med2021https://conductscience.org/library/papers/34188688PubMed
1515153310The role of human mast cell-derived cytokines in eosinophil biology.J Interferon Cytokine Res2004https://conductscience.org/library/papers/15153310PubMed
1637220858Efficacy of traditional Chinese exercise (Baduanjin) on patients with stable COPD: A systematic review and meta-analysis.Complement Ther Med2023https://conductscience.org/library/papers/37220858PubMed
1736948499Lung transplantation for COPD/pulmonary emphysema.Eur Respir Rev2023https://conductscience.org/library/papers/36948499PubMed
1835435466
Effects of inhaled corticosteroids (ICS) on lung microbiota and local immune response in long-term treatment of chronic obstructive pulmonary disease (COPD): utility of titration and therapeutic index.
Naunyn Schmiedebergs Arch Pharmacol2022https://conductscience.org/library/papers/35435466PubMed
1931730394Genetics of COPD.Annu Rev Physiol2020https://conductscience.org/library/papers/31730394PubMed
2037312153Regulation of whole-transcriptome sequencing expression in COPD after personalized precise exercise training: a pilot study.Respir Res2023https://conductscience.org/library/papers/37312153PubMed

See all 76 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41994406The efficacy of Qingjin Huazhuo Decoction combined with acupuncture therapy on pulmonary function and quality of life in patients with acute exacerbation of chronic obstructive pulmonary disease.Pak J Med Sci2026https://conductscience.org/library/papers/41994406

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39276358

GET https://conductscience.org/api/papers/v1/39276358/references?page=2